Personal information

Keywords

Thyroid Diseases, Graves Disease, Osteoporosis, hyperparathyrodism, Calcitropic hormones

Countries

Sweden

Activities

Collapse all

Employment (7)

Karolinska Institutet: Stockholm, Stockholm County, SE

2001-09 to 2015-02 | Senior Lecturer, Director Medical Education (Clinical Research and Education)
Employment
Source: Self-asserted source
Ove Torring

Rigshospitalet: Kobenhavn, DK

1995-09 to 1999-09 | Senior Consultant (Endocrinology)
Employment
Source: Self-asserted source
Ove Torring

Karolinska Universitetssjukhuset: Stockholm, SE

1978-12 to 1995-09 | Physician, Senior Consultant (Endocrinology)
Employment
Source: Self-asserted source
Ove Torring

Mayo Clinic Research Minnesota: Rochester, MN, US

1989-07-01 to 1990-07-01 | Visiting Scientist (Endocrine Research Unit)
Employment
Source: Self-asserted source
Ove Torring

KaroBio AB: Huddinge, SE

1989-02-01 to 1989-06-30 | Senior Medical Advisor
Employment
Source: Self-asserted source
Ove Torring

Mayo Clinic Research Minnesota: Rochester, MN, US

1987-04-01 to 1987-07-01 | Visiting Scientist (Endocrine Research Unit)
Employment
Source: Self-asserted source
Ove Torring

Södersjukhuset: Stockholm, SE

1974-08-01 to 1978-11-30 | Physician (Medicine)
Employment
Source: Self-asserted source
Ove Torring

Education and qualifications (3)

Karolinska Institutet: Stockholm, Stockholm County, SE

1992-06 to present | Associate Professor (Docent) (Endocrinology)
Education
Source: Self-asserted source
Ove Torring

Karolinska Institutet: Stockholm, Stockholm County, SE

1985-06-05 to present | PhD (Endocrinology)
Education
Source: Self-asserted source
Ove Torring

Aarhus Universitet: Aarhus, DK

1967-09-01 to 1974-06-24 | M.D.
Education
Source: Self-asserted source
Ove Torring

Works (2)

Hypoglycemia after exposure of diclofenac medication

Endocrine
2022-11-14 | Journal article
DOI: 10.1007/s12020-022-03252-z
Contributors: Henrik Falhammar; Ove Törring; Martin Larsson; David Nathanson
Source: check_circle
Crossref

Three Sisters With Heterozygous Gene Variants of CYP24A1: Maternal Hypercalcemia, New-Onset Hypertension, and Neonatal Hypoglycemia

Journal of the Endocrine Society
2019-02-01 | Journal article
DOI: 10.1210/js.2018-00337
Contributors: Fredric Hedberg; Christina Pilo; Johan Wikner; Ove Törring; Jan Calissendorff
Source: check_circle
Crossref
How many people are using ORCID?